Investing.com - Biogen (NASDAQ:BIIB) Inc reported third quarter earnings that beat analyst's expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $7.15 on revenue of $3.44B. Analysts polled by Investing.com anticipated EPS of $6.79 on revenue of $3.33B. That compared to EPS of $6.31 on revenue of $3.08B in the same period a year earlier. The company had reported EPS of $5.8 on revenue of $3.36B in the previous quarter.
For the year, Biogen Inc shares are down 1.75%, under-performing the S&P 500 which is up 2.69% year to date.
Biogen Inc follows other major Healthcare sector earnings this month
On Tuesday, October 16, 2018, J&J (NYSE:JNJ) reported third quarter EPS of $2.05 on revenue of $20.35B, compared to forecasts of EPS of $2.03 on revenue of $20.04B.
Novartis ADR earnings beat analyst's expectations on Thursday, with third quarter EPS of $1.32 on revenue of $12.78B. Investing.com analysts expected EPS of $1.31 on revenue of $12.98B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar